Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Arcturus Therapeutics Holdings Inc (NQ:ARCT)

19.48 +0.25 (+1.30%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 994,178
Open 19.21
Bid (Size) 18.00 (1)
Ask (Size) 19.48 (40)
Prev. Close 19.23
Today's Range 18.81 - 19.79
52wk Range 8.040 - 25.88
Shares Outstanding 26,562,951
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga

Performance

YTD
+14.1%
+14.1%
1 Month
+51.6%
+51.6%
3 Month
+67.2%
+67.2%
6 Month
+7.9%
+7.9%
1 Year
-3.8%
-3.8%

More News

Read More
Intapp Posts Better-Than-Expected Earnings, Joins Sapiens International, Arcturus Therapeutics, Gildan Activewear And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Mercury Systems Posts Better-Than-Expected Earnings, Joins Green Dot, Arcturus Therapeutics And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Earnings Scheduled For May 12, 2025
Via Benzinga
Beyond The Numbers: 8 Analysts Discuss Arcturus Therapeutics Stock
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Top movers in Tuesday's session
Via Chartmill
Arcturus Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Via Benzinga
Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress
From Arcturus Therapeutics Holdings Inc.
Via Business Wire
Earnings Scheduled For August 11, 2025
Via Benzinga
Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on August 11, 2025
From Arcturus Therapeutics Holdings Inc.
Via Business Wire
Arcturus Therapeutics to Attend Upcoming Investor Conferences
From Arcturus Therapeutics Holdings Inc.
Via Business Wire
Expert Outlook: Arcturus Therapeutics Through The Eyes Of 5 Analysts
Via Benzinga
Arcturus Therapeutics Announces Positive Interim Phase 2 Multiple Dose Data for Ornithine Transcarbamylase (OTC) Deficiency Program
From Arcturus Therapeutics Holdings Inc.
Via Business Wire
Arcturus Therapeutics to Host Key Opinion Leader (KOL) Presentation of ARCT-810 Phase 2 Interim Data for Ornithine Transcarbamylase (OTC) Deficiency
From Arcturus Therapeutics
Via Business Wire
Arcturus Therapeutics to Attend Upcoming Investor Conferences
From Arcturus Therapeutics Holdings Inc.
Via Business Wire
Which stocks are moving before the opening bell on Tuesday?
Via Chartmill
Demystifying Arcturus Therapeutics: Insights From 7 Analyst Reviews
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Which stocks are moving after the closing bell on Monday?
Via Chartmill
Arcturus Therapeutics Announces First Quarter 2025 Financial Update and Pipeline Progress
From Arcturus Therapeutics Holdings Inc.
Via Business Wire
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 12, 2025
From Arcturus Therapeutics Holdings Inc.
Via Business Wire
Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for the STARR® mRNA Vaccine Candidate ARCT-2304 for Pandemic Influenza A Virus H5N1
From Arcturus Therapeutics Holdings Inc.
Via Business Wire
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2024 Financial Update and Pipeline Progress
From Arcturus Therapeutics Holdings Inc.
Via Business Wire

Frequently Asked Questions

Is Arcturus Therapeutics Holdings Inc publicly traded?
Yes, Arcturus Therapeutics Holdings Inc is publicly traded.
What exchange does Arcturus Therapeutics Holdings Inc trade on?
Arcturus Therapeutics Holdings Inc trades on the Nasdaq Stock Market
What is the ticker symbol for Arcturus Therapeutics Holdings Inc?
The ticker symbol for Arcturus Therapeutics Holdings Inc is ARCT on the Nasdaq Stock Market
What is the current price of Arcturus Therapeutics Holdings Inc?
The current price of Arcturus Therapeutics Holdings Inc is 19.48
When was Arcturus Therapeutics Holdings Inc last traded?
The last trade of Arcturus Therapeutics Holdings Inc was at 08/15/25 04:00 PM ET
What is the market capitalization of Arcturus Therapeutics Holdings Inc?
The market capitalization of Arcturus Therapeutics Holdings Inc is 517.45M
How many shares of Arcturus Therapeutics Holdings Inc are outstanding?
Arcturus Therapeutics Holdings Inc has 517M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.